参考文献/References:
[1]漆洪波,童超.从母胎界面着眼探究子痫前期的发病机制[J].中国实用妇科与产科杂志,2020,36(1):61-64. [2]Esteve-Valverde E,Ferrer-Oliveras R,Gil-Aliberas N,et al.Pravastatin for preventing and treating preeclampsia:a systematic review[J].Obstet Gynecol Surv,2018,73(1):40-55. [3]Sircar M,Thadhani R,Karumanchi SA.Pathogenesis of preeclampsia[J].Curr Opin Nephrol Hypertens,2015,24(2):131-138. [4]Maynard SE,Karumanchi SA.Angiogenic factors and preeclampsia[J].Semin Nephrol,2011,31(1):33-46. [5]Mohini K,Bellary N,Chandra R,et al.Late postpartum pre-eclampsia with posterior reversible encephalopathy syndrome[J].J Adv Med Dent Sci Res,2017,5(9):102-103. [6]Giwa AI,Nguyen M.Late onset postpartum preeclampsia 3 months after delivery[J].Am J Emerg Med,2017,35(10):1582. [7]Ali SM,Khalil RA.Genetic,immune and vasoactive factors in the vascular dysfunction associated with hypertension in pregnancy[J].Expert Opin Ther Tar,2015,19(11):1495-1515. [8]Yang X,Meng T.MicroRNA-431 affects trophoblast migration and invasion by targeting ZEB1 in preeclampsia[J].Gene,2018(683):225-232. [9]El-Sayed AAF.Preeclampsia:a review of the pathogenesis and possible management strategies based on its pathophysiological derangements[J].Taiwan J Obstet Gyne,2017,56(5):593-598. [10]李雪芳,侯文杰.重度子痫前期患者再次妊娠血压状态及相关危险因素分析[J].新医学,2020,51(12):943-946. [11]何敏敏.唐雅兵.再发子痫前期危险因素分析[J].中国妇产科临床杂志,2019,20(4):57-59. [12]张超,韩洁,苏妍,等.妊娠期高血压疾病的相关危险因素[J].实用临床医药杂志,2016,20(9):193-194. [13]巴哈尔古丽·阿不来提,玛依拉·买买提,祖丽皮亚·依明,等.妊娠期高血压疾病的相关危险因素及其严重程度对母婴结局的影响[J].中国妇幼保健,2018,33(19):4380-4383. [14]刘亚静.重度子痫前期相关高危因素分析[J].临床医药文献电子杂志,2019,6(13):24-25. [15]Spradley FT,Palei AC,Granger JP.Increased risk for the development of preeclampsia in obese pregnancies:weighing in on the mechanisms[J].Am J Physiol-Reg I,2015,309(11):1326-1343. [16]甘冰,杨燕嫣,李敏,等.子痫前期发病危险因素分析[J].中国妇产科临床杂志,2013,14(6):64-66. [17]Jim B,Karumanchi SA.Preeclampsia:pathogenesis,prevention,and long-term complications[J].Semin Nephrol,2017,37(4):386-397. [18]Falco ML,Sivanathan J,Laoreti A,et al.Placental histopathology associated with pre-eclampsia:systematic review and meta-analysis[J].Ultrasound Obstet Gyn,2017,50(3):295-301. [19]Gathiram P,Moodley J.Pre-eclampsia:its pathogenesis and pathophysiolgy:review articles[J].Cardiovasc J Afr,2016,27(2):71-78. [20]Pereira RD,Nicole E,Wang RC,et al.Angiogenesis in the placenta: the role of reactive oxygen species signaling[J].Biomed Res Int,2015(2015):1-12. [21]Karumanchi SA.Angiogenic factors in preeclampsia from diagnosis to therapy[J].Hypertension,2016,67(6):1072-1079. [22]Sultana Z,Maiti K,Aitken J,et al.Oxidative stress,placental ageing-related pathologies and adverse pregnancy outcomes[J].Am J Reprod Immunol,2017,77(5):12653. [23]Tomimatsu T,Mimura K,Endo M,et al.Pathophysiology of preeclampsia:an angiogenic imbalance and long-lasting systemic vascular dysfunction[J].Hypertens Res,2017,40(4):305-310. [24]Anto EO,Roberts P,Turpin CA,et al.Oxidative stress as a key signaling pathway in placental angiogenesis changes in preeclampsia:updates in pathogenesis,novel biomarkers and therapeutics[J].Current Pharmacogenomics Personalized Medicine,2018,(16):167-181. [25]Lu HQ,Hu R.The role of immunity in the pathogenesis and development of preeclampsia[J].Scand J Immunol,2019,90(5):1-12. [26]Thompson LP,Pence L,Pinkas G,et al.Placental hypoxia during early pregnancy causes maternal hypertension and placental insufficiency in the hypoxic guinea pig model[J].Biol Reprod,2016,95(6):1-10. [27]Yusuf AM,Kahane A,Ray JG.First and second trimester serum sFlt-1/PlGF ratio and subsequent preeclampsia:a systematic review[J].J Obstet Gynaecol Can,2018,40(5):618-626. [28]Malshe AK,Sibai BM.Angiogenic and antiangiogenic markers for prediction and risk classification of preeclampsia[J].Clin Obstet Gynaecol,2017,60(1):134-140. [29]Li H,Ohta H,Tahara Y,et al.Artificial oxygen carriers rescue placental hypoxia and improve fetal development in the rat pre-eclampsia model[J].Sci Rep-UK,2015(5):15271. [30]Zamudio S,Wu Y,Ietta F,et al.Human placental hypoxia-inducible factor-1alpha expression correlates with clinical outcomes in chronic hypoxia in vivo[J].Am J Pathol 2007,170(6):2171-2179. [31]周晓霞,刘晓颖.11β-HSD2与TNF-α在妊娠期高血压疾病病人胎盘组织中的表达及意义[J].内蒙古医科大学学报,2017,39(5):402-407 [32]Cerdeira AS,Agrawal A,Staff AC,et al.Angiogenic factors: potential to change clinical practice in pre-eclampsia[J].BJOG-Int J Obstet Gy,2018,125(11):1389-1395 [33]Tong W,Giussani DA.Preeclampsia link to gestational hypoxia[J].J Dev Orig Hlth Dis,2019,10(3):1-12. [34]Schoots MH,Gordijn SJ,Scherjon SA,et al.Oxidative stress in placental pathology[J].Placenta,2018(69):153-161. [35]Sircar M,Thadhani R,Karumanchi SA.Pathogenesis of preeclampsia[J].Curr Opin Nephrol Hy,2015,24(2):131-138. [36]Reshef T.The role of hypoxia and hypoxia-Inducible factor-1alpha in preeclampsia pathogenesis[J].Biol Reprod,2012,87(6):134. [37]Lai H,Liu H.Expression and meaning analysis of HIF-1α and HSP70 in preeclamptic placenta[J].Biomed Res-India,2018,29(6):1240-1243. [38]Yu N,Wu JL,Xiao J,et al.HIF-1α regulates angiogenesis via Notch1/STAT3/ETBR pathway in trophoblastic cells[J].Cell Cycle,2019,18(24):3502-3512. [39]Mahdiyeh HS,Leila K,Batool T,et al.The association of the placental,hypoxia-inducible factor1-α,polymorphisms and HIF1-α mRNA expression with preeclampsia[J].Placenta,2018(67):31-37. [40]Albers R,Kaufman MR,Natale B,et al.Trophoblast-specific expression of Hif-1α results in preeclampsia-like symptoms and fetal growth restriction[J].Sci Rep-UK,2019,9(1):2742. [41]Saleh L,Danser JA,van den Meiracker AH.Role of endothelin in preeclampsia and hypertension following antiangiogenesis treatment[J].Curr Opin Nephrol Hypertens,2016,25(2):94-99. [42]彭志清,史秋兰,董春艳,等.妊娠高血压患者TNF-a、IL-6、ET、NO水平变化及意义[J].医学信息,2014,27(3)6:140-141. [43]George EM,Granger JP.Endothelin:key mediator of hypertension in preeclampsia[J].Am J Hypertens,2011,24(9):964-949. [44]Wang YP,Alexander JS.Placental pathophysiology in preeclampsia[J].Pathophysiology,2000,6(4):261-270. [45]Saleh L,Verdonk K,Danser AHJ,et al.Sflt-1 and plgf measurements and their ratio for the diagnosis and prognosis of preeclampsia in a high-risk cohort[J].J Hypertens,2015(33):110. [46]石紫云,张雅,赵静,等.激活PPAR-γ对妊娠高血压大鼠模型ET-1/ETAR信号通路的影响[J].山西医科大学学报,2020,51(2):158-164. [47]Kakui K,Sagawa N,Itoh H,et al.Expression of nitric:oxide synthase isoforms in the human placenta is not altered by labor[J].Endocr J,2003,50(5):535-544. [48]Du L,He F,Kuang L,et al.eNOS/iNOS and endoplasmic reticulum stress-induced apoptosis in the placentas of patients with preeclampsia[J].J Hum Hypertens,2017,31(1):49-55. [49]Zou Y,Jiang Z,Yu X,et al.MiR-101 regulates apoptosis: of trophoblast HTR-8/SVneo cells by targeting endoplasmic reticulum(ER)protein 44 during preeclampsia[J].J Hum Hypertens,2014,28(10):610-616. [50]Mao L,Zhou Q,Zhou S,et al.Roles of apolipoprotein E(ApoE)and inducible nitric oxide synthase(iNOS)in inflammation and apoptosis in preeclampsia pathogenesis and progression[J].PLoS One,2013,8(3):58168. [51]Yin HL,Luo CW,Dai ZK,et al.Hypoxia-inducible factor-1α,vascular endothelial growth factor,inducible nitric oxide synthase,and endothelin-1 expression correlates with angiogenesis in congenital heart disease[J]. Kaohsiung J Med Sci,2016,32(7):348-355. [52]王乐,巴依尔才次克,李明霞.热休克蛋白70对缺氧性肺动脉高压新生大鼠肺的保护作用[J].中华实用儿科临床杂志,2017,32(6):451-456. [53]Matsubara K,Higaki T,Matsubara Y,et al.Nitric oxide and reactive oxygen species in the pathogenesis of preeclampsia[J].Int J Mol Sci,2015,16(3):4600-4614. [54]Zheng L,Huang J,Su Y,et al.Overexpression of tissue factor pathway inhibitor 2 attenuates trophoblast proliferation and invasion in preeclampsia[J].Hum Cell,2020,33(3):512-520. [55]Sheridan MA,Yang Y,Jain A,et al.Early onset preeclampsia in a model for human placental trophoblast[J].P Natl Acad Sci USA,2019,116(10):4336-4345.
相似文献/References:
[1]李仲均,黄丽姗,曾带娣,等.孕妇血清维生素A、维生素E、25-羟基维生素D与
子痫前期的相关性研究[J].医学信息,2019,32(11):63.[doi:10.3969/j.issn.1006-1959.2019.11.018]
LI Zhong-jun,HUANG Li-shan,ZENG Dai-di,et al.Correlation between Serum Vitamin A,Vitamin E,25-hydroxyvitamin D and
Pre-eclampsia in Pregnant Women[J].Medical Information,2019,32(04):63.[doi:10.3969/j.issn.1006-1959.2019.11.018]
[2]尤 鑫,崔洪艳.PDGF与子痫前期相关性的研究进展[J].医学信息,2019,32(17):53.[doi:10.3969/j.issn.1006-1959.2019.17.017]
YOU Xin,CUI Hong-yan.Advances in Research on the Relationship between PDGF and Preeclampsia[J].Medical Information,2019,32(04):53.[doi:10.3969/j.issn.1006-1959.2019.17.017]
[3]蒋峰丽,马亚楠,乌 丽.胎盘生长因子在子痫前期早期诊断中的临床价值[J].医学信息,2019,32(16):160.[doi:10.3969/j.issn.1006-1959.2019.16.054]
JIANG Feng-li,MA Ya-nan,WU Li.Clinical Value of Placental Growth Factor in Early Diagnosis of Preeclampsia[J].Medical Information,2019,32(04):160.[doi:10.3969/j.issn.1006-1959.2019.16.054]
[4]王金凤,王克涛.红细胞压积、血清纤维蛋白原、D-二聚体及尿白蛋白/尿肌酐比值在子痫前期诊断中的价值[J].医学信息,2020,33(20):156.[doi:10.3969/j.issn.1006-1959.2020.20.049]
WANG Jin-feng,WANG Ke-tao.The Value of Hematocrit,Serum Fibrinogen,D-dimer and Urine Albumin/Urinary Creatinine Ratio in the Diagnosis of Preeclampsia[J].Medical Information,2020,33(04):156.[doi:10.3969/j.issn.1006-1959.2020.20.049]
[5]史爱红,刘爱玲,封 玲,等.凝血功能指标对不同类型子痫前期的诊断价值[J].医学信息,2020,33(21):90.[doi:10.3969/j.issn.1006-1959.2020.21.026]
SHI Ai-hong,LIU Ai-ling,FENG Ling,et al.The Diagnostic Value of Coagulation Function Indexes for Different Types of Preeclampsia[J].Medical Information,2020,33(04):90.[doi:10.3969/j.issn.1006-1959.2020.21.026]
[6]车 莹,杨 丽,孙 昊.前瞻性护理对妊娠高血压轻度子痫前期患者血压及自我管理能力的影响[J].医学信息,2022,35(02):190.[doi:10.3969/j.issn.1006-1959.2022.02.051]
CHE Ying,YANG Li,SUN Hao.Effect of Prospective Nursing on Blood Pressure and Self-management Ability of Patientswith Mild Preeclampsia of Pregnancy-induced Hypertension[J].Medical Information,2022,35(04):190.[doi:10.3969/j.issn.1006-1959.2022.02.051]
[7]马梦茹,吴胜军,赵宗霞,等.子痫前期患者相关生化指标的研究进展[J].医学信息,2022,35(22):176.[doi:10.3969/j.issn.1006-1959.2022.22.043]
MA Meng-ru,WU Sheng-jun,ZHAO Zong-xia,et al.Research Progress of Biochemical Indexes in Patients with Preeclampsia[J].Medical Information,2022,35(04):176.[doi:10.3969/j.issn.1006-1959.2022.22.043]
[8]刘腾雁,戴丽芬,彭娅萍,等.缺氧诱导因子-1α对OSAHS患者糖代谢的影响研究[J].医学信息,2023,36(01):189.[doi:10.3969/j.issn.1006-1959.2023.01.042]
LIU Teng-yan,DAI Li-fen,PENG Ya-ping,et al.Effect of Hypoxia-inducible Factor-1α on Glucose Metabolism in Patients with OSAHS[J].Medical Information,2023,36(04):189.[doi:10.3969/j.issn.1006-1959.2023.01.042]
[9]霍春霞,谢 玲,张爱萍.早期干预治疗对早期筛查阳性子痫前期孕妇妊娠结局的影响[J].医学信息,2023,36(19):134.[doi:10.3969/j.issn.1006-1959.2023.19.029]
HUO Chun-xia,XIE Ling,ZHANG Ai-ping.Effect of Early Intervention on Pregnancy Outcome of Pregnant Women with Early Screening Positive Preeclampsia[J].Medical Information,2023,36(04):134.[doi:10.3969/j.issn.1006-1959.2023.19.029]
[10]郭 丽,黄淑娟,隋红梅.子痫前期的药物预防研究[J].医学信息,2023,36(23):170.[doi:10.3969/j.issn.1006-1959.2023.23.043]
GUO Li,HUANG Shu-juan,SUI Hong-mei.Research on Drug Prevention of Preeclampsia[J].Medical Information,2023,36(04):170.[doi:10.3969/j.issn.1006-1959.2023.23.043]